gastric neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients scheduled for ESD for gastric neoplasms
Exclusion criteria
Exclusion criteria: cases in which informed consent was not obtained for the study, cases in which part of the lesion extends to either the cardia or the pyloric ring, cases in which ulceration after resection of the lesion extends to 1/2 circumferential of the stomach, cases with severe organ failure, cases with abnormal blood clotting function with high bleeding risk, cases in which perforation was evident at the time of lesion resection, cases during pregnancy, patients in a situation where an urgent and obvious life crisis has occurred for some reason, and other cases that the attending physician or surgeon deems inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete closure rate | — |
Secondary
| Measure | Time frame |
|---|---|
| procedure time, number of clips used, number of traction devices used, ulcer closure rate on postoperative day 3, incidence of post-ESD bleeding and delayed perforation, incidence of PECS, incidence of other adverse events, ulcer healing rate 1 month after closure | — |
Countries
Japan
Contacts
The Jikei University School of Medicine Department of Endoscopy